Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains.
complement
glomerulonephritis
immunology
Journal
Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
17
04
2020
revised:
11
09
2020
accepted:
17
09
2020
pubmed:
2
11
2020
medline:
22
6
2021
entrez:
1
11
2020
Statut:
ppublish
Résumé
C3 glomerulopathy is characterized by accumulation of complement C3 within glomeruli. Causes include, but are not limited to, abnormalities in factor H, the major negative regulator of the complement alternative pathway. Factor H-deficient (Cfh
Identifiants
pubmed: 33129896
pii: S0085-2538(20)31237-0
doi: 10.1016/j.kint.2020.09.028
pmc: PMC7863913
pii:
doi:
Substances chimiques
Complement C3
0
Complement C5
0
Immunoglobulin G
0
Properdin
11016-39-0
Complement Factor H
80295-65-4
Complement C3-C5 Convertases
EC 3.4.21.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
396-404Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212252/Z/18/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Références
Kidney Int. 2019 Mar;95(3):655-665
pubmed: 30655025
J Immunol. 2013 Apr 1;190(7):3552-9
pubmed: 23427256
Mol Immunol. 2006 Mar;43(7):972-9
pubmed: 16023208
J Am Soc Nephrol. 2013 Jan;24(1):43-52
pubmed: 23184055
J Exp Med. 2007 Jun 11;204(6):1249-56
pubmed: 17517971
Clin Exp Immunol. 1986 Aug;65(2):450-7
pubmed: 3641695
Nat Genet. 2002 Aug;31(4):424-8
pubmed: 12091909
Kidney Int. 2010 Aug;78(3):279-86
pubmed: 20445496
Clin Exp Immunol. 2016 Apr;184(1):118-25
pubmed: 26660535
J Immunol. 2018 Jan 1;200(1):316-326
pubmed: 29187587
J Immunol. 1976 Jan;116(1):1-7
pubmed: 1245733
Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46
pubmed: 21566112
Mol Immunol. 2009 Jun;46(10):1942-50
pubmed: 19411110
J Am Soc Nephrol. 2017 May;28(5):1462-1474
pubmed: 27932477
Front Immunol. 2017 Sep 19;8:1145
pubmed: 28974948
Am J Pathol. 1993 Jan;142(1):179-87
pubmed: 7678717
Clin Exp Immunol. 1986 Jul;65(1):73-9
pubmed: 3641694
J Am Soc Nephrol. 2011 Jan;22(1):137-45
pubmed: 21148255
J Am Soc Nephrol. 2013 Jan;24(1):53-65
pubmed: 23204401
Kidney Int Rep. 2019 Jun 19;4(10):1387-1400
pubmed: 31701048
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82
pubmed: 25341722
Clin Exp Immunol. 2008 Feb;151(2):210-30
pubmed: 18190458
J Immunol. 2015 Nov 15;195(10):4986-98
pubmed: 26459349
J Immunol. 2013 Jun 1;190(11):5712-21
pubmed: 23616575
J Exp Med. 2006 Mar 20;203(3):789-97
pubmed: 16520389
J Am Soc Nephrol. 2018 Jun;29(6):1649-1661
pubmed: 29588430
Clin Exp Immunol. 1997 Dec;110(3):403-9
pubmed: 9409643
Kidney Int. 2015 Dec;88(6):1314-1322
pubmed: 26221753
Nat Rev Nephrol. 2010 Aug;6(8):494-9
pubmed: 20606628
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4685-90
pubmed: 23487775
Nat Rev Nephrol. 2019 Mar;15(3):129-143
pubmed: 30692664
J Am Soc Nephrol. 2016 Feb;27(2):405-16
pubmed: 26047789